Planta Med 2006; 72(6): 533-538
DOI: 10.1055/s-2006-931559
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Alkyl Phloroglucinol Derivatives from Syzygium levinei and their Differentiation-Inducing Activity

Jian Zou1 , 2 , [*] , Yi Mi2 , 3 , [*] , Wenliang Chen1 , 2 , Qunfang Liu1 , Jian Wang1 , Liguang Lou3 , Weimin Zhao1
  • 1Department of Natural Products Chemistry, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, P. R. China
  • 2Graduate School of the Chinese Academy of Sciences, Shanghai, P. R. China.
  • 3Department of Pharmacology, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, P. R. China
Further Information

Weimin Zhao

Department of Natural Products Chemistry

Shanghai Institute of Materia Medica

Shanghai Institutes for Biological Sciences

Chinese Academy of Sciences

Shanghai 201203

People’s Republic of China

Email: wmzhao@mail.shcnc.ac.cn

Publication History

Received: July 26, 2005

Accepted: December 8, 2005

Publication Date:
28 April 2006 (online)

Table of Contents #

Abstract

Eleven compounds have been identified from the whole plants of Syzygium levinei (Myrtaceae) on the basis of spectroscopic analysis and chemical methods. Among these compounds, (Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-oct-5-en-1-one (1), (3E,7Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-deca-3,7-dien-1-one (2), and 1-(2-O-β-D-glucopyranosyl-5,6-dihydroxy-4-methoxyphenyl)-octan-1-one (3) were characterized as new alkyl phloroglucinol derivatives, and 1-(2,6-dihydroxy-4-methoxyphenyl)-hexan-1-one (4) was identified as a new natural product. Compounds 1, 2, and 4 were found to inhibit the proliferation of leukemia K562 and HL-60 cells and also to induce the differentiation of K562 cells as determined by the appearance of matured morphology and the increase in the intracellular hemoglobin level.

#

Introduction

Syzygium levinei (Myrtaceae) is an arborous species widely distributed in the south of China [1]. Previous phytochemical investigations of the genus Syzygium led to the identification of flavones [2], triterpenoids [2], tannins [3], and phenolic compounds [4], [5]. Pharmacological studies indicated that several constituents and extracts of Syzygium plants possess immunostimulant [2], antiviral [4], antimutagenic [5], antibacterial [5], and antioxidant activities [6]. To the best of our knowledge, no chemical study has been made on the species Syzygium levinei. As a continuation of our efforts to find new antitumor natural products from Chinese folk medicines, the petroleum ether extract of S. levinei was found to exhibit cytotoxicity against Ramos Burkitt’s lymphoma B cells. Further bioassay-guided isolation and systematic isolation led to the identification of three new alkyl phloroglucinol derivatives as (Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-oct-5-en-1-one (1), (3E,7Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-deca-3,7-dien-1-one (2), and 1-(2-O-β-D-glucopyranosyl-5,6-dihydroxy-4-methoxyphenyl)-octan-1-one (3), a new natural alkyl phloroglucinol derivative 1-(2,6-dihydroxy-4-methoxyphenyl)-hexan-1-one (4) [7] along with seven other known compounds (5 - 11). In addition, the effect of compounds 1, 2, and 4 on cellular proliferation and differentiation in leukemia cells was investigated.

Zoom Image
#

Materials and Methods

#

General

Optical rotations were measured with a Perkin-Elmer 241MC polarimeter or a Perkin-Elmer 341 polarimeter. UV spectra were recorded with a Beckman DU-7 spectrometer. IR spectra were recorded using a Perkin-Elmer 577 spectrometer. LR-ESI-MS were measured using a Finnigan LCQ-DECA instrument, and HR-ESI-MS data were obtained on a Mariner spectrometer. LR-EI-MS were obtained on a MAT-95 spectrometer, and HR-EI-MS on a Kratos 1H spectrometer. NMR spectra were run on a Bruker AM 400 spectrometer with TMS as internal standard. Preparative HPLC was carried out using a Varian SD-1 instrument, equipped with a Merck NW25 C18 column (10 μm, 20 mm × 250 mm), and ProStar 320 UV/Vis detector. GC analysis was performed with a Shimadzu model GC-MS-QP5050A instrument equipped with a DB-1 column (0.25 mm i. d. × 30 m), and in the EI ionization mode. Column chromatographic separations were carried out using a LiChroprep RP-18 Lobar column (40 - 63 μm, Merck) and using silica gel H60 (300 - 400 mesh), zcx-II (100 - 200 mesh) (Qingdao Haiyang Chemical Group Corporation; Qingdao, P. R. China), and Sephadex LH-20 (Pharmacia Biotech AB; Uppsala, Sweden) as packing materials. HSGF254 silica gel TLC plates (Yantai Chemical Industrial Institute; Yantai, P. R. China) and RP-18 WF254 TLC plates (Merck) were used for analytical TLC. Human erythroleukemia K562, human myelogenous leukemia HL-60 and Burkitt’s lymphoma Ramos cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). The cell lines were maintained at 37 °C (5 % CO2) in tissue culture dishes filled with growth medium (RPMI 1640 medium with 10 % heat-inactivated fetal bovine serum, 100 kU/L penicillin, and 200 kU/L streptomycin). Reagents for biological assays including benzidine dihydrochloride, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and all other reagents were purchased from Sigma Co. (St. Louis, MO, USA). Compounds 1, 2 and 4 were stored at -20 °C as 100 mM solutions in ethanol. The solutions were diluted at least 1000-fold in the growth medium so that the final concentration of solvent was less than 0.1 %, which had no effect on the cell proliferation and differentiation.

#

Plant material

The whole plants of Syzygium levinei were collected in the suburb of Guangzhou, Guangdong province, P. R. China, in May 2003, and identified by Professor Zexian Li of the South China Institute of Botany, Chinese Academy of Sciences. A voucher specimen (No. SIMMW0306) is deposited in the Herbarium of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences.

#

Extraction and isolation

Powdered air-dried whole plants of Syzygium levinei (3.0 kg) were percolated with 95 % ethanol (10 L × 3) at room temperature. The filtrate was concentrated to dryness under vacuum and then suspended in 20 % ethanol overnight. After filtration of the precipitated chlorophyll and evaporation of ethanol in the filtrate, the aqueous residue (1 L) was extracted with petroleum ether, ethyl acetate, and n-butanol (1.0 L × 3), successively, to give a petroleum ether fraction (5.5 g), an ethyl acetate fraction (23.0 g), and an n-butanol fraction (41.5g), respectively. The petroleum ether fraction (5.5 g) was subjected to chromatography over a silica gel H60 column (3.5 cm i. d. × 25 cm) with a petroleum ether-acetone gradient (10 : 1, 8 : 1, 5 : 1, 2 : 1, 1 : 1, 0 : 1, each 500 mL) as eluent to give Fr. A1 (between 0 and 600 mL, 550 mg), Fr. A2 (between 600 and 1100 mL, 1.36 g), Fr. A3 (between 1100 and 3000 mL, 2.85 g). A part of Fr. A2 (100.6 mg) was further purified over a preparative HPLC column (2.0 cm i. d. × 25 cm, RP-18), eluted with a methanol-water gradient (65 % - 80 %, 10 mL/min, 1 - 75min, 750 mL) to afford 4 (between 450 mL and 490 mL, 16.8 mg), 1 (between 520 mL and 570 mL, 21.4 mg), and 2 (between 610 mL and 660 mL, 30.4 mg). The n-butanol extract (41.5 g) was separated over a silica gel H60 column (10 cm i. d. × 25 cm) eluted with a chloroform-methanol gradient (10 : 1, 1.5 L; 5 : 1, 1.5 L; 3 : 1, 1.0 L; 2 : 1, 1.0 L; 1 : 1, 1.0 L; 0 : 1, 500 mL) to give Fr. C1 (between 0 and 1100 mL, 2.65 g), Fr. C2 (between 1100 and 1900 mL, 4.90 g), Fr. C3 (between 1900 and 3100 mL, 5.62 g), Fr. C4 (between 3100 and 4200 mL, 5.15 g), Fr. C5 (between 4200 and 5500 mL, 6.80 g), and Fr. C6 (between 5500 and 6500 mL, 11.5 g). Fr. C3 (5.62 g) was separated over a silica gel H60 column (3.5 cm i. d. × 20 cm), eluted with a chloroform-methanol gradient (10 : 1, 5 : 1, 3 : 1, 2 : 1, 1 : 1, 0 : 1, each 400 mL) to give Fr. C3A (between 0 and 750 mL, 550 mg), Fr. C3B (between 750 and 1150 mL, 860 mg), Fr. C3C (between 1150 and 1700 mL, 1.82 g) and Fr. C3D (between 1700 and 2400 mL, 1.40 g). Fr. C3B (between 750 and 1150 mL, 860 mg) was separated over a LiChroprep RP-18 Lobar column eluted with methanol-water (30 %, 50 %, 70 % each 100 mL) to give 3 (between 148 mL and 175 mL, 12.5 mg).

Syzygiol A (1): amorphous white powder; UV (MeOH): λmax = 286, 229 nm; IR (KBr): νmax = 3303, 2953, 2852, 1635, 1589, 1520, 1429, 1375, 1317, 1234, 1203, 1078 cm-1; LR-EI-MS: m/z (rel. int.) = 264 [M]+ (7), 182 (42), 167 (100); HR-EI-MS: m/z = 264.1368 [M]+ (calcd. for C15H20O4: 264.1361); 1H- and 13C-NMR data: see Table [1] and Table [2].

Syzygiol B (2): amorphous white powder; UV (MeOH): λmax = 289, 230 nm; IR (KBr): νmax = 3315, 3007, 2962, 1635, 1585, 1520, 1429, 1356, 1217, 1161, 1084 cm-1; LR-EI-MS: m/z (rel. int.) = 290 [M]+ (10), 167 (100), 149 (18); HR-EI-MS: m/z = 290.1521 [M]+ (calcd. for C17H22O4: 290.1508); 1H- and 13C-NMR data: see Table [1] and Table [2].

Syzygioside (3): amorphous white powder; [α]D 21: -90.0° (c 0.02, methanol); UV (MeOH): λmax = 289, 229 nm; IR (KBr): νmax = 3408, 2924, 1625, 1595, 1450, 1427, 1230, 1207, 1167, 1074, 1047cm-1; LR-ESI-MS (positive-ion mode): m/z = 483.1 [M + Na]+; LR-ESI-MS (negative-ion mode): m/z = 459.0 [M - H]-; HR-ESI-MS (negative-ion mode): m/z = 459.1828 [M - H]- (calcd. for C20H31O11: 459.1866); 1H- and 13C-NMR data: see Table [1] and Table [2].

The structures of eight known compounds, 1-(2,6-dihydroxy-4-methoxyphenyl)-hexan-1-one (4), 2α,3β,19α,24-tetrahydroxyurs-12-en-28-oic acid (5) [8], [9], myricitrin (6) [10], [11], quercitrin (7) [10], [11], 2,4,6-trimethoxyphenyl-1-O-β-D-(6′-O-galloyl)-glucopyranoside (8) [12], 2α,3α,19α,24-tetrahydroxyurs-12-enoic acid 28-O-β-D-glucopyranosyl ester (9) [13], 2,4,6-trimethoxyphenyl-O-β-D-glucopyranoside (10) [14], [15], and n-butyl-β-D-fructopyranoside (11) [16] were determined by comparison of the physicochemical data with those reported in literature (see Supporting Information).

#

Acidic hydrolysis of compound 3

Compound 3 (2 mg) dissolved in 50 % methanol (1.0 mL) containing 5 % HCl was heated in a boiling water bath for 5 hours. After cooling, the reaction mixtures were neutralized with 10 % Na2CO3 and glucose was identified as its sugar moiety by co-TLC of the aqueous solution with authentic glucose sample (EtOAc-MeOH-H2O-HOAc, 13 : 3:3 : 4, Rf = 0.46).

#

Absolute configuration of glucose

A solution in pyridine (300 μL) of the hydrolyzed sugar from 3 (0.01 mol/L) and L-cysteine methyl ester hydrochloride (0.02 mol/L) were mixed and warmed at 60 °C for 1 h. Acetic anhydride (200 μL) was then added, and the mixture was warmed at 90 °C for another 1 h. After evaporation of pyridine and acetic anhydride under vacuum, the residue was dissolved in acetone (500 μL) and the solution (1 μL) was subjected to GLC [17]. A peak for the peracetylated thiazolidine derivatives with a retention time at 11.87 min was observed, which was identical to the derivatives of authentic D-glucose prepared in the same manner.

#

Determination of cell proliferation by MTT assay

Cells (5 × 104 cells/mL) were incubated with different concentrations of compounds 1, 2 and 4 for 72 hours. Cell proliferation was determined with the MTT assay as described previously [18]. The assays were carried out in triplicate in at least three independent experiments.

#

Morphological studies

Cells (5 × 104 cells/mL) were treated with each compond for 5 days. Cells were collected by centrifugation, fixed with methanol, stained with Giemsa staining solution, and observed under a microscope as described [18].

#

Determination of erythroid differentiation by benzidine test

Cells (5 × 104 cells/mL) were treated with each compound for 5 days. The percentage of cells staining for hemoglobin was estimated by staining with benzidine/H2O2 essentially as previously described [19]. The blue-stained hemoglobin-positive cells were counted under a microscope. At least 120 cells were assessed for each sample.

#

Supporting information

Extraction and isolation of known compounds, the physicochemical data of known compounds, and 1H-1H COSY and main HMBC correlation signals of 1 - 3.

Table 1 1H-NMR data (400 MHz) of compounds 1 - 3 (δ ppm)
No. 1a 2a 3b
3 5.95, s 5.95, s 6.31, d (2.0)
5 5.95, s 5.95, s 6.11, d (2.0)
2′ 3.09, t (7.5) 3.81, d (6.6) 3.20, t (7.4)
3′ 1.79, tt (7.6, 7.5) 5.71, dt (15.3, 6.6) 1.90, m; 1.70, m
4′ 2.10, dt (5.0, 7.6) 5.60, dt (15.4, 6.3) 1.59, m; 1.50, m
5′ 5.38, dt (11.9, 5.0) 2.10, m 3.43, m
6′ 5.40, dt (11.9, 5.0) 2.08, m 3.30, m
7′ 2.05, dq (7.6, 5.0) 5.33, dt (10.9, 6.7) 1.57, m; 1.41, m
8′ 0.97, t (7.6) 5.36, dt (10.7, 6.7) 0.99, t (7.5)
9′ - 2.00, dq (7.5, 6.7) -
10′ - 0.97, t (7.5) -
4-OCH3 3.78, s 3.78, s 3.80, s
glc-1 - - 5.04, d (7.7)
glc-2 - - 3.55, dd (8.3, 7.7)
glc-3 - - 3.48, dd (8.3, 9.2)
glc-4 - - 3.38, dd (9.2, 9.5)
glc-5 - - 3.47, m
glc-6 - - 3.89, dd (12.1, 2.0); 3.68, dd (12.2, 5.7)
a In CDCl3.
b In CD3OD.
Table 2 13C-NMR data (100 MHz) of compounds 1 - 3 (δ ppm)
No. 1a 2a 3b
1 104.6, C 104.4, C 107.8, C
2 163.1, C 163.1, C 162.2, C
3 93.9, CH 94.0, CH 95.0, CH
4 165.2, C 165.6, C 167.8, C
5 93.9, CH 94.0, CH 96.8, CH
6 163.1, C 163.1, C 167.5, C
1′ 206.2, C 204.0, C 208.0, C
2′ 43.1, CH2 47.1, CH2 45.6, CH2
3′ 24.3, CH2 122.7, CH 22.7, CH2
4′ 26.4, CH2 133.8, CH 33.9, CH2
5′ 128.0, CH 32.5, CH2 75.3, CH
6′ 132.0, CH 26.5, CH2 77.3, CH
7′ 20.2, CH2 127.9, CH 27.7, CH2
8′ 14.0, CH3 131.7, CH 11.0, CH3
9′ - 20.2, CH2 -
10′ - 13.9, CH3 -
4-OCH3 55.1, CH3 55.1, CH3 56.4, CH3
glc-1 - - 102.3, CH
glc-2 - - 75.1, CH
glc-3 - - 78.8, CH
glc-4 - - 71.6, CH
glc-5 - - 78.9, CH
glc-6 - - 62.8, CH2
a In CDCl3.
b In CD3OD.
#

Results and Discussion

Compound 1 was obtained as a white amorphous powder with an elemental formula of C15H20O4 determined by HR-EI-MS (m/z = 264.1368, [M]+). Its UV absorptions maximized at 286, 229 nm, suggesting an aromatic moiety in its structure. The IR spectrum of 1 revealed the existence of hydroxy group (3303 cm-1), aromatic ring (1589, 1520, 1429 cm-1) and ketone (1635 cm-1) in its structure. In the 13C-NMR spectrum of 1, 15 carbon signals including two methyls, four methylenes, four sp 2 methines, and five sp 2 quaternary carbons were observed. In the NMR spectra of 1, a singlet at δH = 5.95 (2H, s), along with four carbon signals [δC = 104.6 (C-1), 93.9 (C-3/C-5), 163.1 (C-2/C-6), 165.2 (C-4)], suggested the existence of a symmetrical phloroglucinol subunit. Two olefinic protons were found at δH = 5.38 (1H, dt, J = 11.9, 5.0 Hz), 5.40 (1H, dt, J = 11.9, 5.0 Hz). Analysis of 1H-1H COSY and HSQC spectra revealed fragments: -C-2′-C-3′-C-4′-C-5′-C-6′-C-7′-C-8′- in its structure. The planar structure of 1 was established on the basis of its HMBC NMR spectra, in which 13C-1H long-range correlation signals were observed at C-1/H-3, H-5; C-4/4-OCH3; C-1′/H-3, H-5, H-3′; C-4′/H-2′, H-6′; C-5′/H-3′, H-7′; C-8′/H-6′. The Z configuration of the double bond was identified from the comparison of its 13C-NMR data with those of (Z)-3-heptene and its 3-E-isomer [20], which was further confirmed by the 1H-1H coupling constant of the olefinic protons (J = 11.9 Hz). The allylic carbon at δC = 20.2 (C-7′) and the olefinic carbons [δC = 132.0 (C-6′), 128.0 (C-5′)] were identical with those of the 3-Z-isomer [allylic carbon: δC = 20.9 (C-2); olefinic carbon: δC = 131.9 (C-3) and 129.2 (C-4)], but not those of the 3-E-isomer [allylic carbon: δC = 25.9 (C-2); olefinic carbon: δC = 132.4 (C-3) and 129.4 (C-4)]. Finally, the structure of 1 was determined as (Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-oct-5-en-1-one, and has been assigned the trivial name syzygiol A.

Compound 2 was obtained as a white amorphous powder with an elemental formula of C17H22O4 determined by HR-EI-MS (m/z = 290.1521, [M]+). Its 1H- and 13C-NMR spectra were very similar to those of 1 except for two more sp 2 methine carbons, which indicated it to be also a linear alkylene phloroglucinol with two double bonds in the side chain. In the NMR spectra of 2, a singlet at δH = 5.95 (2H, s), along with four carbon signals [δC = 104.4 (C-1), 94.0 (C-3/C-5), 163.1 (C-2/C-6), 165.6 (C-4)], suggested the existence of a symmetrical phloroglucinol subunit. Four olefinic protons were found at δH = 5.33 (1H, dt, J = 10.9, 6.7 Hz), 5.36 (1H, dt, J = 10.7, 6.7 Hz), 5.60 (1H, dt, J = 15.4, 6.3 Hz) and 5.71 (1H, dt, J = 15.3, 6.6 Hz), which indicated the existence of two double bonds in its structure. Analysis of its 1H-1H-COSY and HSQC spectra revealed fragments: -C-2′-C-3′-C-4′-C-5′-C-6′-C-7′-C-8′-C-9′-C-10′- in its structure. The planar structure of 2 was established on the basis of its HMBC spectra, in which 13C-1H long-range correlation signals were observed at C-1/H-3, H-5; C-4/4-OCH3; C-1′/H-3, H-5, H-3′; C-4′/H-2′, H-6′; C-5′/H-3′, H-7′; C-6′/H-8′; C-7′/H-9′; C-8′/H-5′, H-9′, H-10′. The Z configuration of the double bond at Δ7 was determined using the same method as mentioned in 1 [20]. The stereochemistry of the double bond at Δ3 was determined as E by comparison of its 13C-NMR data with those of E-3-octenoic acid ethyl ester and its 3-Z-isomer [21], which was further confirmed by the 1H-1H coupling constants of the olefinic protons (J = 15.3 Hz). Thus structure of 2 was characterized to be (3E,7Z)-1-(2,6-dihydroxy-4-methoxyphenyl)-deca-3,7-dien-1-one, and has been assigned the trivial name syzygiol B.

Compound 3 was obtained as a white amorphous powder with an elemental formula of C21H32O11 determined by HR-ESI-MS (m/z = 459.1866, [M - H]-). In its 13C-NMR spectrum, 21 carbon signals including two methyls, five methylenes, nine methines (two for sp 2), and four sp 2 quaternary carbons were observed. In the 1H-NMR spectrum of 3, an anomeric proton was found at δH = 5.04 (1H, d, J = 7.7 Hz), two meta-coupled protons at δH = 6.31 (1H, d, J = 2.0 Hz) and 6.11(1H, d, J = 2.0 Hz) revealed the existence of a 1,2,3,5-tetrasubstituted benzene ring, which was confirmed by four sp 2 quaternary carbon signals [δC = 107.8 (C-1), 162.2 (C-2), 167.8 (C-4), 167.5 (C-6)], and two sp 2 methine signals [δC = 95.0 (C-3), 96.8 (C-5)]. Acid hydrolysis of 3 gave the glucose as the sugar moiety by co-TLC with an authentic sample. The 1H-1H coupling constant (J = 7.7 Hz) of the anomeric proton indicated the glucose unit to be in the β-glycosidic form. The absolute configuration of glucose in 3 was found to belong to the D series by GC analysis of the peracetylated thiazolidine derivative [17]. Preliminary analysis of 1H-1H-COSY and HSQC spectra enabled the deduction of fragments -C-2′, C-3′, C-4′, C-5′, C-6′, C-7′, C-8′- in its structure. The planar structure of 3 was established on the basis of its HMBC spectra, in which 13C-1H long range correlation signals were observed at C-1/H-3, H-5; C-2/Hglc-1; C-4/4-OCH3; C-1′/H-3′; C-4′/H-2′; C-5′/H-3′, H-7′; C-6′/H-4′, H-8′. The structure of 3 was further confirmed by the NOE correlation signals between H-3 and Hglc-1; H-3 and 7-OCH3; H-5 and 7-OCH3; H-2′ and H-3′; H-3′ and H-4′; H-4′ and H-5′; H-5′ and H-6′; H-6′ and H-7′; H-6′ and H-8′; H-7′ and H-8′ in its NOESY spectrum. The structure of 3 was determined as 1-(2-O-β-D-glucopyranosyl-5,6-dihydroxy-4-methoxyphenyl)-octan-1-one, and has been assigned the trivial name syzygioside.

Compound 4 was identified as 1-(2,6-dihydroxy-4-methoxyphenyl)-hexan-1-one by spectroscopic analysis and comparison of the NMR data with those reported in literature [5].

Differentiation therapy is a novel approach for the treatment of leukemia in which immature leukemia cells are induced to attain a mature phenotype when exposed to differentiation inducers, either alone or in combination with other chemotherapeutic or chemopreventive drugs. One successful example is the use of all-trans-retinoic acid in the treatment of acute myeloid leukemia, which is much safer and more effective than conventional chemotherapy [22]. Thus it is important to find new compounds with differentiation-inducing activity. Previous studies have shown that compound 4 is a synthetic DIF analogue [23] and possesses antiproliferative and differentiation-inducing effects on erythroid leukemia K562 cells [24]. Compounds 1 and 2 are analogues of 4, therefore, the three compounds were tested together for their effects on the proliferation and differentiation of HL-60 and K562 cells with 4 as a positive control. As shown in Fig. [1], compounds 1, 2 and 4 inhibited the proliferation of K562 cells (Fig. [1] A) and HL-60 cells (Fig. [1] B) in a concentration-dependent manner, with IC50 values of 14.39 μM, 27.90 μM, 15.96 μM for K562 cells and 16.44 μM, 31.57 μM, 18.71 μM for HL-60 cells, respectively.

The morphology of K562 cells was changed after 5 days incubation with various concentrations of 1 or 4. After treatment with 10 μM of 1 or 4, the cells showed a prominent perinuclear vacuole or cytoplasmic inclusion, accentuation of cytoplasmic blebbing, and a decreased nuclear-to-cytoplasmic ratio. Compound 2 did not show significant morphological effects on K562 cells (Fig. [2]). To confirm K562 cell differentiation, the functional changes in K562 cells induced by 1, 2 and 4 were analyzed. As shown in Fig. [3], after 5 days of incubation with 2.5 - 20 μM of 1, 2 and 4, the percentage of benzidine-positive cells in K562 cells was significantly increased, which indicated that compounds 1 and 4 do indeed induce the differentiation of K562 cells. However, compounds 1, 2 and 4 (5 - 20 μM) did not induce significant morphological changes in HL-60 cells (data not shown).

Zoom Image

Fig. 1 Effect of compounds 1, 2 and 4 on the proliferation of K562 (A) and HL-60 (B) cells. Cells were treated with various concentrations of compounds 1, 2 and 4 for 72 h, and cell proliferation was determined with the MTT assay. Data represent the mean ± standard deviation of three independent experiments.

Zoom Image

Fig. 2 Effect of compounds 1, 2 and 4 on the morphology of K562 cells. K562 cells were treated with 10 μM of compounds 1, 2 and 4 for 5 days, then fixed and stained with Giemsa.

Zoom Image

Fig. 3 Effects of compounds 1, 2 and 4 on the intracellular hemoglobin level of K562 cells. Cells were treated with compounds 1, 2 and 4 for 5 days, and the intracellular hemoglobin level was assessed by benzidine stain. Data represent the mean and standard deviation of three independent experiments. *P < 0.01; ** P < 0.001 (by Student’s t-test).

#

Acknowledgements

The authors are grateful to Shanghai Committee of Science and Technology for partial financial support (No. 03DZ19228 and No. 034 319 229).

#

References

  • 1 Hong Kong Herbarium, South China Institute of Botany. Checklist of Hong Kong plants. Hong Kong; Agriculture, Fisheries and Conservation Department Press 2001: p 130
  • 2 Srivastava R, Shaw A K, Kulshreshtha D KK. Triterpenoids and chalcone from Syzygium samarangense .  Phytochemistry. 1995;  38 687-9
  • 3 Tanaka T, Oriib Y, Nonaka G I, Nishioka I, Kouno I. Syzyginins A and B, two ellagitannins from Syzygium aromaticum .  Phytochemistry. 1996;  43 1345-8
  • 4 Charles R, Garg S N, Kumar S. An orsellinic acid glucoside from Syzygium aromatica .  Phytochemistry. 1998;  49 1375-6
  • 5 Miyazawa M, Hisama M. Antimutagenic activity of phenylpropanoids from clove (Syzygium aromaticum).  J Agric Food Chem. 2003;  51 6413-22
  • 6 Banerjee A, Dasgupta N, De B. In vitro study of antioxidant activity of Syzygium cumini fruit.  Food Chem. 2005;  90 727-33
  • 7 Dorit A. Novel anti-viral compounds. WO 9 747 270 1997
  • 8 Terreaux C, Maillard M P, Gupta M P, Hostettmann K. Triterpenes and triterpene glycosides from Paradrymonia macrophylla .  Phytochemistry. 1996;  42 495-9
  • 9 Houghton P J, Lian L M. Triterpenoids from Desfontainia spinosa .  Phytochemistry. 1986;  25 1939-44
  • 10 Zhong X N, Otsuka H, Ide T, Hirata E, Takushi A, Takeda Y. Three flavonol glycosides from leaves of Myrsine seguinii .  Phytochemistry. 1997;  46 943-6
  • 11 Fossen T, Larsen Å, Kiremire B T, Andersen O M. Flavonoids from blue flowers of Nymphaea caerulea .  Phytochemistry. 1999;  51 1133-7
  • 12 Nonaka G I, Nishimura H, Nishioka I. Tannins and related compounds. IV. Seven phenol glucoside gallates from Quercus stenophylla Makino.  Chem Pharm Bull. 1982;  30 2061-7
  • 13 Li B Z, Wang B G, Jia Z J. Pentacyclic triterpenoids from Rubus xanthocarpus .  Phytochemistry. 1998;  49 2477-81
  • 14 Saijo R, Nonaka G, Nishioka I. Phenol glucoside gallates from Mallotus japonicus .  Phytochemistry. 1989;  28 2443-6
  • 15 Liu X, Zhao D, Wang H. Phenolic compounds from Celastrus angulatus .  J Indian Chem Soc. 2002;  79 259-60
  • 16 Zhang C Z, Xu X Z, Li C. Fructosides from Cynomoriun songaricum .  Phytochemistry. 1996;  41 975-6
  • 17 Hara S, Okabe H, Mihashi K. Gas-liquid chromatographlic separation of aldose enantiomers as trimethylsilyl ethers of methyl 2-(polyhydroxyalkyl)-thiazolidine-4(R)-carboxylates.  Chem Pharm Bull. 1987;  35 501-6
  • 18 Kim S H, Kim T S. Synergistic induction of 1,25-dihydroxyvitamin D3- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps .  Planta Med. 2002;  68 886-90
  • 19 Tabilio A, Pelicci P G, Vinci G, Mannoni P, Civin C I, Vainchenker W. et al . Myeloid and megakaryocytic properties of K562 cell lines.  Cancer Res. 1983;  43 4569-74
  • 20 De Haan J W, Van De Ven L JM. Configurations and conformations in acyclic, unsaturated hydrocarbons. a 13C NMR study.  Org Magn Reson. 1973;  5 147-53
  • 21 Kaltia S, Matikainen J, Hase T. ZE Photoisomerization of homoactivated carbon carbon double bonds.  Synth Commun. 1991;  21 1083-6
  • 22 Sachs L. The control of hematopoiesis and leukemia: from basic biology to the clinic.  Proc Natl Acad Sci USA. 1996;  93 4742-9
  • 23 Masento M S, Morris H R, Taylor G W, Johnson S J, Skapski A C, Kay R R. Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues.  Biochem J. 1988;  256 23-8
  • 24 Kubohara Y. Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent.  Eur J Pharmacol. 1999;  381 57-62

1 These authors contribute equally to this work

Weimin Zhao

Department of Natural Products Chemistry

Shanghai Institute of Materia Medica

Shanghai Institutes for Biological Sciences

Chinese Academy of Sciences

Shanghai 201203

People’s Republic of China

Email: wmzhao@mail.shcnc.ac.cn

#

References

  • 1 Hong Kong Herbarium, South China Institute of Botany. Checklist of Hong Kong plants. Hong Kong; Agriculture, Fisheries and Conservation Department Press 2001: p 130
  • 2 Srivastava R, Shaw A K, Kulshreshtha D KK. Triterpenoids and chalcone from Syzygium samarangense .  Phytochemistry. 1995;  38 687-9
  • 3 Tanaka T, Oriib Y, Nonaka G I, Nishioka I, Kouno I. Syzyginins A and B, two ellagitannins from Syzygium aromaticum .  Phytochemistry. 1996;  43 1345-8
  • 4 Charles R, Garg S N, Kumar S. An orsellinic acid glucoside from Syzygium aromatica .  Phytochemistry. 1998;  49 1375-6
  • 5 Miyazawa M, Hisama M. Antimutagenic activity of phenylpropanoids from clove (Syzygium aromaticum).  J Agric Food Chem. 2003;  51 6413-22
  • 6 Banerjee A, Dasgupta N, De B. In vitro study of antioxidant activity of Syzygium cumini fruit.  Food Chem. 2005;  90 727-33
  • 7 Dorit A. Novel anti-viral compounds. WO 9 747 270 1997
  • 8 Terreaux C, Maillard M P, Gupta M P, Hostettmann K. Triterpenes and triterpene glycosides from Paradrymonia macrophylla .  Phytochemistry. 1996;  42 495-9
  • 9 Houghton P J, Lian L M. Triterpenoids from Desfontainia spinosa .  Phytochemistry. 1986;  25 1939-44
  • 10 Zhong X N, Otsuka H, Ide T, Hirata E, Takushi A, Takeda Y. Three flavonol glycosides from leaves of Myrsine seguinii .  Phytochemistry. 1997;  46 943-6
  • 11 Fossen T, Larsen Å, Kiremire B T, Andersen O M. Flavonoids from blue flowers of Nymphaea caerulea .  Phytochemistry. 1999;  51 1133-7
  • 12 Nonaka G I, Nishimura H, Nishioka I. Tannins and related compounds. IV. Seven phenol glucoside gallates from Quercus stenophylla Makino.  Chem Pharm Bull. 1982;  30 2061-7
  • 13 Li B Z, Wang B G, Jia Z J. Pentacyclic triterpenoids from Rubus xanthocarpus .  Phytochemistry. 1998;  49 2477-81
  • 14 Saijo R, Nonaka G, Nishioka I. Phenol glucoside gallates from Mallotus japonicus .  Phytochemistry. 1989;  28 2443-6
  • 15 Liu X, Zhao D, Wang H. Phenolic compounds from Celastrus angulatus .  J Indian Chem Soc. 2002;  79 259-60
  • 16 Zhang C Z, Xu X Z, Li C. Fructosides from Cynomoriun songaricum .  Phytochemistry. 1996;  41 975-6
  • 17 Hara S, Okabe H, Mihashi K. Gas-liquid chromatographlic separation of aldose enantiomers as trimethylsilyl ethers of methyl 2-(polyhydroxyalkyl)-thiazolidine-4(R)-carboxylates.  Chem Pharm Bull. 1987;  35 501-6
  • 18 Kim S H, Kim T S. Synergistic induction of 1,25-dihydroxyvitamin D3- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps .  Planta Med. 2002;  68 886-90
  • 19 Tabilio A, Pelicci P G, Vinci G, Mannoni P, Civin C I, Vainchenker W. et al . Myeloid and megakaryocytic properties of K562 cell lines.  Cancer Res. 1983;  43 4569-74
  • 20 De Haan J W, Van De Ven L JM. Configurations and conformations in acyclic, unsaturated hydrocarbons. a 13C NMR study.  Org Magn Reson. 1973;  5 147-53
  • 21 Kaltia S, Matikainen J, Hase T. ZE Photoisomerization of homoactivated carbon carbon double bonds.  Synth Commun. 1991;  21 1083-6
  • 22 Sachs L. The control of hematopoiesis and leukemia: from basic biology to the clinic.  Proc Natl Acad Sci USA. 1996;  93 4742-9
  • 23 Masento M S, Morris H R, Taylor G W, Johnson S J, Skapski A C, Kay R R. Differentiation-inducing factor from the slime mould Dictyostelium discoideum and its analogues.  Biochem J. 1988;  256 23-8
  • 24 Kubohara Y. Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent.  Eur J Pharmacol. 1999;  381 57-62

1 These authors contribute equally to this work

Weimin Zhao

Department of Natural Products Chemistry

Shanghai Institute of Materia Medica

Shanghai Institutes for Biological Sciences

Chinese Academy of Sciences

Shanghai 201203

People’s Republic of China

Email: wmzhao@mail.shcnc.ac.cn

Zoom Image
Zoom Image

Fig. 1 Effect of compounds 1, 2 and 4 on the proliferation of K562 (A) and HL-60 (B) cells. Cells were treated with various concentrations of compounds 1, 2 and 4 for 72 h, and cell proliferation was determined with the MTT assay. Data represent the mean ± standard deviation of three independent experiments.

Zoom Image

Fig. 2 Effect of compounds 1, 2 and 4 on the morphology of K562 cells. K562 cells were treated with 10 μM of compounds 1, 2 and 4 for 5 days, then fixed and stained with Giemsa.

Zoom Image

Fig. 3 Effects of compounds 1, 2 and 4 on the intracellular hemoglobin level of K562 cells. Cells were treated with compounds 1, 2 and 4 for 5 days, and the intracellular hemoglobin level was assessed by benzidine stain. Data represent the mean and standard deviation of three independent experiments. *P < 0.01; ** P < 0.001 (by Student’s t-test).